Analysts expect Cartesian Therapeutics, Inc. to report revenue of 170,036.99 for Q2 26, against a range of 160,026.06 to 180,047.92. The most recent reported quarter, Q1 26, came in at 78,000.00, a 63.5% miss against the 213,506.03 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 5.84 M | 33.27 M | 387,000.00 | 1.10 M | 298,000.00 | 452,000.00 | 947,000.00 | 78,000.00 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 1.67 M | 7.36 M | 1.40 M | 994,204.58 | 974,874.10 | 283,906.90 | 151,791.29 | 230,658.46 | 180,047.92 | 199,766.21 | 305,648.55 | 89,745.40 | 155,400.93 | 158,276.67 | 215,849.58 | 221,746.07 | |||||||||||
| Low Estimate | 1.46 M | 6.59 M | 1.19 M | 887,003.92 | 841,288.10 | 265,345.46 | 131,516.11 | 196,353.60 | 160,026.06 | 181,967.85 | 280,541.45 | 81,060.60 | 143,681.67 | 142,988.09 | 180,483.22 | 186,768.25 | |||||||||||
| Consensus Estimate | 1.56 M | 6.98 M | 1.29 M | 940,604.25 | 908,081.10 | 274,626.18 | 141,653.70 | 213,506.03 | 170,036.99 | 190,867.03 | 293,095.00 | 85,403.00 | 149,541.30 | 150,632.38 | 198,166.40 | 204,257.16 |
Analysts expect Cartesian Therapeutics, Inc. to report earnings per share of -0.92 for Q2 26, against a range of -0.95 to -0.89. The most recent reported quarter, Q1 26, came in at -1.46, a 60.4% miss against the -0.91 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -10.50 | 0.54 | -1.13 | -0.68 | 0.50 | -1.38 | -3.46 | -1.46 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -0.80 | -0.81 | -0.80 | -0.69 | -0.72 | -0.86 | -0.83 | -0.83 | -0.89 | -0.81 | -1.00 | -0.91 | 0.67 | -0.64 | -0.71 | -1.15 | |||||||||||
| Low Estimate | -0.90 | -0.95 | -0.86 | -0.81 | -0.80 | -0.92 | -0.91 | -0.99 | -0.95 | -0.93 | -1.06 | -1.09 | 0.63 | -0.72 | -0.85 | -1.23 | |||||||||||
| Consensus Estimate | -0.85 | -0.88 | -0.83 | -0.75 | -0.76 | -0.89 | -0.87 | -0.91 | -0.92 | -0.87 | -1.03 | -1.00 | 0.65 | -0.68 | -0.78 | -1.19 |